Two new ruthenium(II) complexes [Ru(dmp)(2)(DNPIP)](2+) 1 and [Ru(dmp)(2)(DAPIP)](2+) 2 were synthesized and characterized. The DNA-binding behaviors of these complexes were investigated by absorption spectra, viscosity measurements and photocleavage. The DNA-binding constants for complexes 1 and 2 have been determined to be 6.24 (+/-0.11) x 10(4) and 1.64 (+/-0.49) x 10(4) M-1. The results suggest that complexes 1 and 2 intercalate between the DNA base pairs. Binding stoichiometries were studied through a luminescence-based Job plot. The major inflection points for complexes 1 and 2 at chi = 0.31 and chi = 0.51 were observed. The data were consistent with 2:1 and 1:1 bp [complex]/[DNA] binding mode. Complex 1 shows higher activity than complex 2 against the selected tumor cell lines. In addition, the cellular uptake and antioxidant activity on hydroxyl radical were also explored. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.
Synthesis, cellular uptake, apopotosis, cytotoxicity, cell cycle arrest, interaction with DNA and antioxidant activity of ruthenium(II) complexes
作者:Hong-Liang Huang、Zheng-Zheng Li、Zhen-Hua Liang、Jun-Hua Yao、Yun-Jun Liu
DOI:10.1016/j.ejmech.2011.04.049
日期:2011.8
A new ligand and two ruthenium(II) complexes [Ru(bpy)2(DNPIP)](ClO4)2 1 and [Ru(bpy)2(DAPIP)](ClO4)2 2 were synthesized and characterized. The DNA-binding constants for complexes 1 and 2 were determined to be 2.24 (±0.30) × 105 M−1 (s = 1.29) and 6.34 (±0.32) × 104 M−1 (s = 2.84). The photocleavage of pBR322 DNA by Ru(II) complexes was investigated. The cytotoxicity of complexes 1 and 2 were assessed
合成并表征了一种新的配体和两种钌(II)络合物[Ru(bpy)2(DNPIP)](ClO 4)2 1和[Ru(bpy)2(DAPIP)](ClO 4)2 2。测定复合物1和2的DNA结合常数为2.24(±0.30)×10 5 M -1(s = 1.29)和6.34(±0.32)×10 4 M -1(s = 2.84)。研究了Ru(II)配合物对pBR322 DNA的光裂解作用。配合物1和2的细胞毒性针对三种肿瘤细胞系进行了评估。研究了细胞凋亡和细胞摄取。探索了pGL 3质粒DNA的阻滞测定。通过流式细胞术分析细胞周期停滞。还研究了配体和配合物的抗氧化活性。
Cytotoxicity, apoptosis, interaction with DNA, cellular uptake, and cell cycle arrest of ruthenium(II) polypyridyl complexes containing 4,4′-dimethyl-2,2′-bipyridine as ancillary ligand
作者:Hong-Liang Huang、Zheng-Zheng Li、Xiu-Zhen Wang、Zhen-Hua Liang、Yun-Jun Liu
DOI:10.1080/00958972.2012.713945
日期:2012.9.20
is more active than 2 against selected cancer cell lines. The apoptosis induced by these complexes was studied. Cellular uptake showed that these complexes could enter into the cytoplasm and accumulate in the nuclei. The cellcyclearrest and antioxidantactivity against hydroxyl radicals were also investigated.
两种新的钌 (II) 多吡啶配合物,[Ru(dmb)2(DNPIP)](ClO4)2 (1) (DNPIP = 2-(2,4-二硝基苯基)咪唑并[4,5-f][1,10 ]菲咯啉,dmb = 4,4'-二甲基-2,2'-联吡啶)和 [Ru(dmb)2(DAPIP)](ClO4)2 (2) (DAPIP = 2-(2,4-diaminophenyl)imidazo [4,5f][1,10] 菲咯啉),被合成和表征。这些复合物的 DNA 结合行为已通过 UV-Vis 吸收滴定、粘度测量和光裂解进行了研究。1 和 2 的 DNA 结合常数分别为 7.39 (±0.16) × 104 (s = 2.68) 和 2.73 (±0.16) × 104 (mol L−1)−1 (s = 0.64)。研究了它们作为对不同癌细胞系的细胞毒性剂的评估,针对 BEL-7402、HepG-2 的 IC50 值为 59
作者:Zheng-Zheng Li、Zhen-Hua Liang、Hong-Liang Huang、Yun-Jun Liu
DOI:10.1016/j.molstruc.2011.06.011
日期:2011.8
Two new ruthenium(II) complexes [Ru(dmp)(2)(DNPIP)](2+) 1 and [Ru(dmp)(2)(DAPIP)](2+) 2 were synthesized and characterized. The DNA-binding behaviors of these complexes were investigated by absorption spectra, viscosity measurements and photocleavage. The DNA-binding constants for complexes 1 and 2 have been determined to be 6.24 (+/-0.11) x 10(4) and 1.64 (+/-0.49) x 10(4) M-1. The results suggest that complexes 1 and 2 intercalate between the DNA base pairs. Binding stoichiometries were studied through a luminescence-based Job plot. The major inflection points for complexes 1 and 2 at chi = 0.31 and chi = 0.51 were observed. The data were consistent with 2:1 and 1:1 bp [complex]/[DNA] binding mode. Complex 1 shows higher activity than complex 2 against the selected tumor cell lines. In addition, the cellular uptake and antioxidant activity on hydroxyl radical were also explored. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.
Photo-induced mitochondrial DNA damage and NADH depletion by –NO<sub>2</sub> modified Ru(<scp>ii</scp>) complexes
Ru(ii) PACT agents with a synchronous photo-catalyzed NADH depletion ability were reported for the first time and displayed good activity towards cisplatin-resistant cancer cells upon one- and two-photon excitation.